SOLICITATION NOTICE
A -- Early Phase Clinical Trial Units (EPCTU)
- Notice Date
- 11/19/2020 5:58:33 AM
- Notice Type
- Presolicitation
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- RFP-NIAID-NIH-AI-75N93020R00023
- Response Due
- 11/30/2020 1:00:00 PM
- Archive Date
- 12/15/2020
- Point of Contact
- Michael P. Welsh
- E-Mail Address
-
welshmi@niaid.nih.gov
(welshmi@niaid.nih.gov)
- Description
- The purpose of the anticipated�solicitation is to implement�Phase�0 to Phase II clinical trials, including proof-of-concept studies in healthy and diseased human populations�domestically and internationally�in an expeditious and efficient manner, aided by bioanalysis when necessary.� Additionally, in the event of urgent public health need, Phase III studies may be conducted. The candidate products to be evaluated under the Early Phase Clinical Trial Units (EPCTU) IDIQ contracts could include new or tested investigational products, such as small �molecules; monoclonal antibodies; immunoglobulins; convalescent plasma; passive transfer studies; vaccines; adjuvants; and other immunomodulatory products against infectious diseases, arising within DMID�s preclinical and early product development programs, as well as those arising from other research partners outside of DMID.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/71c41d7bf406451280b9a4e640293e04/view)
- Record
- SN05856780-F 20201121/201119230223 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |